|
|
ICEID
2002 Webcast
Alphabetical Listing by Speaker
A
B C D E
F G H I
J K L M
N O P Q R
S T U V
W X Y Z
Alphabetical
Listing by Speaker |
A- |
Goutam
Adak, Public Health Laboratory Service, London, United
Kingdom
Health Impact of the
Salmonella enterica serotype Enteritidis Phage Type 4
Epidemic
Salma Afifi, U.S. Naval Medical Research
Unit No. 3, Cairo, Egypt
Surveillance for Patients
with Acute Febrile Illness in Egypt
Ole
Alvseike, Norwegian Institute of Public Health, Oslo,
Norway
Sesame-Seed Paste Caused an International Outbreak Due to Salmonella Typhimurium
DT104The
Investigation in Norway
Andrea Ammon, Robert Koch Institute,
Berlin, Germany
Risk Factors for Lyme Borreliosis: A German Case-Control Study
Fred Anderson, Washington County
Department of Public Health and Environment, Stillwater, NM
Outbreaks of Salmonellosis at Elementary Schools Associated with Dissection of Owl Pellets
Ray Arthur, WHO, Geneva, Switzerland
Laboratory Capacity
Update on the WHO Global
Alert and Response Network
Deborah Asnis, Brooklyn, NY
West Nile Virus Infection
|
B- |
P. Bryon Backenson, New York State
Department of Health, Albany, NY
Mapping of West Nile Virus Risk in the Northeast United States Using Multi-Temporal Meteorological Satellite Data
Rajiv
Bahn, All India Institute of Medical Sciences, New Delhi,
India
Rotavirus Vaccines in Development
Michael Baker, ESR, Wellington, New
Zealand
Outbreak Surveillance: An Important Tool for Controlling Communicable Diseases
Joanne
Bartkus, Minnesota Department of Health, Minneapolis,
MN
Antibiotic Susceptibility and
the Mechanisms of Macrolide Resistance in Invasive Group B
Streptococcus, Minnesota, 1998 and 2000
Barry
Beatty, Colorado State University, Fort Collins, CO
Emerging Vectorborne Infections
Ermias
Belay, CDC, Atlanta, GA
Impact of the BSE/vCJD Outbreak:
U.S. Concerns for TSEs
Bradley
Bender, University of Florida, Gainesville, FL
HIV in the Older Patient
Thomas Bertrand, Rhode Island Department
of Health, Providence, RI
Improving Influenza and Pneumococcal
Vaccination Rates for People 65+ in Rhode Island through Coalition
Building Efforts
John
Besser, Minnesota Department of Health, Minneapolis, MN
High Prevalence of Antibiotic
Resistance in Enterotoxigenic E. coli (ETEC); Minnesota 2000-2001
Carina
Blackmore, Florida Department of Health, Jacksonville,
FL
West Nile Virus First Transmission
Season in Florida, 2001More Than 400 Horse Cases and
170 Chicken Seroconversions but Only Sporadic Human Disease
Gail
A. Bolan, California Department of Health Services, Berkeley,
CA
Emerging and Reemerging STDs
David
Bolton, New York State Institute for Basic Research, Staten
Island, NY
The Agent: Prions as Emerging Infectious
Particles
Christopher Bostock, Institute of
Animal Health, Compton, United Kingdom
Foot and Mouth Disease
C.R. Braden, CDC, Atlanta, GA
Microbiologic Testing
to Identify Shiga Toxin-Producing E. coli in HUS Patients:
FoodNet 1997-2001
Corrie
Brown, College of Veterinary Medicine, University of Georgia,
Athens, GA
The Interface of Animal and Human Health
|
C-
|
Johnny
Callahan, Tetracore, Inc., Gaithersburg, MD
Rapid Screening and Identification
of West Nile Virus in Captive and Wild Birds Using Non-Invasive
Environmental Samples and a Portable TaqMan RT-PCR
Linda Canas, Brooks Air Force Base,
San Antonio, TX
A DoD Global Influenza Surveillance
Program
Gail
Cassell, Eli Lilly and Company, Indianapolis, IN
Keynote Session
Prospects for New Antimicrobial
Drug Development: Industry Perspective
Steven
Castle, University of California at Los Angeles, Los Angeles,
CA
Biology of Aging
Michael
Catchpole, PHLS Communicable Disease Surveillance Centre,
London, United Kingdom
CD Electronic Surveillance in the
UK and EU
Martin Cetron, CDC, Atlanta, GA
The World and Its Moving
Parts: An Overview
H.H. Chang, New York State Department of Health, Albany,
NY
Postdiarrheal Hemolytic Uremic
Syndrome in New York State
L.A. Cole, Rutgers University, Newark, NJ
Bioterrorism 2001: Lessons Learned
Guillermo Comach, Lardidev-Biomed,
Universidad de Carabobo, Maracay, Venezuela
Re-introduction of Dengue 3 in
Aragua, Venezuela: Clinical, Epidemiological and Laboratory Features of a New Outbreak
Joanne
Cono, CDC, Atlanta, GA
Smallpox Vaccine and Vaccination
Strategies
Jane Costa, CDC, Atlanta, GA
Ecological Niche Modeling and Differentiation
of Populations of Triatoma Brasiliensis Neiva, 1911,
the Most Important Chagas Disease Vector in Northeastern Brazil
(Hemiptera, Reduviidae, Triatominae)
Jon
Counts, University of Washington, Seattle, WA
Washington Clinical Laboratory InitiativeAssessment of Laboratory Practice
Donita Croft, Wisconsin Division
of Public Health and CDC, Madison, WI
Randomized Trial of Day Care
Staff Education to Improve Parent Knowledge and Attitudes
Regarding Appropriate Antibiotic Use
Theresa
Cromeans, CDC, Atlanta, GA
Detection and Genetic Analysis
of Swine Hepatitis E Virus in Farm Waste
A.B.
Cronquist, CDC, Denver, CO
Multi-State Outbreak of Salmonella
Senftenberg Infections Associated with Green GrapesWestern
States, 2001
John Crump, CDC, Atlanta, GA
Re-estimating the Global Burden of Typhoid Fever
|
D- |
François Dantoine, Epicentre, Paris,
France
In vivo Sensitivity of Plasmodium falciparum to Chloroquine and Sulfadoxine/Pyrimethamine During an Outbreak of Malaria in Burundi, 2001
Debjani
Das, New York Department of Health, New York, NY
Enhanced Emergency Department Surveillance
System Following the World Trade DisasterNew York City,
September 14 to October 10, 2001
Peter
Daszak, Consortium for Conservation Medicine, Palisades,
NY
The Emergence of Infectious Diseases
Among Wildlife and the Origin of Human Zoonoses
Catherine Dentinger, CDC, Anchorage,
AK
An Evaluation of an Educational
Videotape to Prevent Botulism among Alaska Natives
Walter
Dowdle, Task Force for Child Survival and Development,
Atlanta, GA
Overview: Disease Eradication
Scott
Dowell, CDC, Atlanta, GA
Protecting the Nation's
Health in an Era of Globalization: CDC's Global Infectious
Disease Strategy
Peter
Drotman, CDC, Atlanta, GA
Behind the Scenes at the Emerging Infectious
Disease Journal
Keynote Session
Zandra
Duprey, CDC, Atlanta, GA
Emergence of Canine Visceral Leishmaniasis in Dogs in North America
|
E- |
Paul Effler, State of Hawaii Department
of Health, Honolulu, HI
Dengue Fever Outbreak in Hawaii2001
Andrea
Ellis, Center for Infectious Diseases Prevention and Control,
Guelph, Ontario, Canada
Public Health and Policy
Implications of the Recent Large Drinking Water Outbreaks
in Canada
Hammam
El Sakka, U.S. Naval Medical Research Unit No 3, Cairo,
Egypt
The Emergence of Rift Valley Fever
in the Arabian Peninsula, 2000
Mary Evans, Danish Veterinary Institute,
Copenhagen, Denmark
Prevalence of Salmonella spp.
and Campylobacter spp. Following the Discontinued Use of Antimicrobial Growth Promoters in Broilers and Swine in
Denmark
|
F- |
Barry Farr, University of Virginia
Hospital, Charlottesville, VA
Controlling Antimicrobial Resistance
K.A. Feldman, CDC, Fort Collins, CO
Are Martha's Vineyard Landscapers
at Increased Risk for Tularemia?Massachusetts,
2001
David
Fidler, School of Law, Indiana University, Bloomington,
IN
Global Health, Emerging Infectious Diseases, and International Regulations
Ian
Fisher, PHLS Communicable Disease Surveillance Centre,
London, United Kingdom
Real-time International Surveillance
of Antimicrobial Resistance by the Enter-net Surveillance
Network
Collette Fitzgerald, CDC, Atlanta,
GA
Development and Evaluation of PCR-Based
Diagnostics for Identification of Salmonella O Antigens
Based on the rfb Locus
Carol
Tucker Foreman, Consumer Federation of America, Washington,
DC
Food Safety: Perceived
Risk and Public Trust
Stanley
Foster, Rollins School of Public Health, Emory University,
Atlanta, GA
Clinical and Epidemiologic
Features of Smallpox
Arthur
Friedlander, U.S. Army Medical Research Institute of Infectious
Diseases, Fort Detrick, MD
Anthrax Vaccines
|
G- |
Kathryn Gay, CDC, Atlanta, GA
Quinupristin/Dalfopristin-Resistant
Enterococcus faecium Isolated from Human Stools, Retail
Chicken, and Retail Pork: EIP Enterococci Project
Julie Gerberding, CDC, Atlanta, GA
Patient Safety: Applying Industrial
Quality Models in Healthcare Settings to Improve Outcomes
Iain
Gillespie, Public Health Laboratory Service, London, United
Kingdom
The Acquisition of Ciprofloxacin
Resistance in Travel-Associated and Home-Acquired Campylobacter
jejuni Infection: A Case-Case Comparison
Carol Glaser, California Department
of Health Services, Berkeley, CA
Clusters of Clinical Syndromes
in Patients with Unexplained Encephalitis
Yves
Goguet, Stanford University, Stanford, CA
Tuberculosis Gene Deletion
Typing, Not YATM ("Yet Another Typing Method")
Michael Gottlieb, Los Angeles, CA
AIDS
C.M. Greene, CDC, Atlanta, GA
Rapid Adaptation of a Serologic
Assay for the Bioterrorism-Related Anthrax OutbreakOctober-December,
2001
Daniele Grondin, International Organization for Migration, Geneva, Switzerland
Global Migration and Emerging
Infectious Diseases
Duane
Gubler, CDC, Fort Collins, CO
Emerging Vectorborne Infections
Philippe
Guerin, Epicentre, Paris, France
Shigella dysenteriae
Serotype 1 in West Africa: Intervention Strategy for an Outbreak
in Sierra Leone, 1999-2000
Marta Guerra, CDC, Atlanta, GA
Epidemiology of Raccoon and Skunk
Rabies in the Eastern United States
|
H- |
Anne
Haddix, School of Public Health, Emory University, Atlanta,
GA
Prevention Effectiveness
James Hadler, Connecticut Department
of Public Health, Hartford, CT
Inhalation Anthrax of Unknown Source
Lucinda Hammond, Colorado Department
of Public Health and Environment, Denver, CO
The Emergence of Serogroup Y
Disease and the Epidemiology of Invasive Meningococcal Disease in Colorado, 1997-2001
Francois-Xavier
Hanon, Statens Serum Institut, Copenhagen, Denmark
Challenges in the Interpretation
of Classical and Molecular Epidemiology Results; Two Calicivirus
Outbreaks Due to Oysters, Denmark at New Year 2000
Peter
L. Havens, Medical College of Wisconsin, Milwaukee, WI
Clinical Management of Smallpox
Patients
Dagmar
Heim, Swiss Federal Veterinary Office, Bern-Liebefeld,
Switzerland
The Reservoir: Bovine Spongiform
Encephalopathy and What's Been Done About It
Richard
Hoffman, University of Colorado Health Sciences Center,
Denver, CO
Bioterrorism
A. Hoffmaster, CDC, Atlanta, GA
Importance of Bacillus anthracis
Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated
Anthrax Outbreak in the United States
T.H. Holtz, New York City Department
of Health, New York, NY
Inhalational AnthraxNew York City, October-November 2001
Paul
Hoover, University of Arizona, Tucson, AZ
A Molecular Approach to the Epidemiology
of Giardia duodenalis in a Peruvian Shantytown
V.P. Hsu, CDC, Atlanta, GA
An Anthrax Outbreak
Averted: Public Health Response to a Contaminated Envelope
on Capitol Hill, Washington, DC, 2001
William
Hueston, College of Veterinary Medicine, University of
Minnesota, St. Paul, MN
Surveillance of Livestock for Zoonotic
Diseases and Veterinary Bio-Threat Agents
James
Hughes, Director, National Center for Infectious Diseases,
CDC, Atlanta, GA
Keynote Session
Bioterrorism Preparedness: Lessons,
Challenges, and Opportunities
Donald
Hunt, University of Virginia, Charlottesville, VA
Proteomics and Pathogen Discovery
Susan Hunter, CDC, Atlanta, GA
PulseNet Experience: Software Changes
and Improvements to Online E. coli National Database
|
I- |
Lisa Indar-Harrinauth, University of the West Indies, St. Augustine, Trinidad
and Tobago
Changing Epidemiological
Patterns of Salmonella serotype Enteritidis in Barbados:
Implications for Tourism and Trade
|
J- |
Michele Jay, California Department
of Health Services, Sacramento, CA
A Neighborhood Outbreak of Q Fever
Linked to a Goat Ranch in California
|
K- |
Marilyn Kacica, New York State Department
of Health, Albany, NY
Influenza Surveillance in New York
State, 1998-2001
Brad Kay, WHO, Lyon, France
Laboratory Capacity
M.H.
Kennedy, CDC, Atlanta, GA
Risk Factors for Sporadic
Escherichia coli O157 Infections in the United States:
A Case-Control Study in FoodNet Sites, 1999-2000
Asheena
Khalakdina, University of California at Berkeley, Berkeley,
CA
Is Drinking Water a Risk Factor for
Endemic Cryptosporidiosis in the Immunocompetent General Population
of the San Francisco Bay Area?
Kamal
Kishore, Fiji School of Medicine, Suva, Fiji
Threat Letter Menace: The Fiji
Experience
Keith
Klugman, School of Public Health, Emory University, Atlanta,
GA
Global Drug Resistance: The Case of Streptococcus pneumoniae
Jeffrey
Koplan, Director, CDC, Atlanta, GA
Keynote Session
Leslie
Kux, U.S. Food and Drug Administration, Rockville, MD
Foodborne Disease
|
L- |
Marcelle Layton, New York Department
of Health, New York, NY
Cutaneous Anthrax in New York City
Ji-Eun Lee, Department of Defense
Global Emerging Infections System, Silver Spring, MD
Analysis of a Health
Indicator Surveillance System: Its Ability to Detect Annual
Influenza Activity for the 1999-2000 and 2000-2001 Seasons
Compared to Traditional Surveillance Systems
Mira Leslie, Arizona Department of
Health Services, Phoenix, AZ
Emerging Zoonoses: A Novel Epizootic of Skunks Infected with a Bat Variant of Rabies
David
Levin, University of Victoria, Victoria, BC, Canada
Monitoring of Human Exposure to
Bacillus thuringiensis After Aerial Applications
for Insect Control
Margaret
Ann Liu, Bill and Melinda Gates Foundation, Seattle, WA
New Technologies and Vaccine
Development
Wilfredo
Lopez, New York City Department of Health, New York, NY
West Nile Virus in New
York City
Ben
Lopman, Public Health Laboratory Service, London, UK
Foodborne Viruses in Europe: Web-Based Technologies for Investigation of Transnational Outbreaks of Viral Gastroenteritis
|
M- |
Brian
Mahy, CDC, Atlanta, GA
Behind the Scenes at the Emerging Infectious
Disease Journal
Philip Makutsa, CARE International
in Kenya, Homa Bay, Kenya
Increasing Water Vessel Use
in Kenya
Bela Matyas, Massachusetts Department
of Public Health, Jamaica Plain, MA
Active Laboratory Surveillance
in Massachusetts
Donald
Mayo, Connecticut State Health Department, Hartford, CT
Public Health Laboratory Response
to an Anthrax Incident in Connecticut
Rafael Mazin, Pan American Health
Organization HCA/HCP, Washington, DC
Sex Workers as Targets of
and Agents for HIV/STI Prevention
Jennifer
McClellan, CDC, Atlanta, GA
Prevalence and Consequences of
Fluoroquinolone-Resistant Campylobacter Infections:
NARMS 1997-2000
Janet McNicholl, CDC, Atlanta, GA
Genetic Susceptibility to Infectious
Diseases
Jennifer McQuiston, CDC, Atlanta,
GA
Investigation of Q Fever in Bosnia-Herzegovina,
2000: An Example of International Cooperation
Q
Fever in the United States: Experience of Infectious Disease
Consultants and
Comparison to National Reporting During 2000
Martin
Meltzer, CDC, Atlanta, GA
Prevention Effectiveness
Jorge F. Méndez-Galván, Ministry
of Health, Mexico City, Mexico
New Strategies on the Old Ideas: Malaria
Control Without Insecticides and Community Participation in
Aedes aegypti Control, Mexico's Experiences
Leonard Mermel, Rhode Island Hospital,
Providence, RI
Prevention of Intravascular Catheter-Related Infections
Richard
Miller, University of Michigan, Ann Arbor, MI
Biology of Immune Senescence
Christine
Moe, Rollins School of Public Health, Emory University,
Atlanta, GA
The Risk of Food and Water
Contamination from Animal Manure
Kare Molbak, Statens Serum Institut,
Copenhagen, Denmark
Antimicrobial Resistance in Salmonella
Serotype Typhimurium, R-Type ACSSuT, is Associated with Bacteremia:
NARMS 1996-2000
Anne Moore, CDC, Atlanta, GA
Trypanosomiasis as a Reemerging Infection
Farzad
Mostashari, Bureau of Communicable Disease, New York City
Department of Health, New York, NY
BT Surveillance in NYC
Peter
Mugyenyi, Joint Clinical Research Center, Kampala, Uganda
Use of Antiretroviral Agents in Developing
Countries
Andy
Mullins, CDC, Atlanta, GA
Changes in Circulating Enterovirus
Serotypes in the United States, 2001
Gerald Mumma, CDC, Atlanta, GA
Evidence of Effectiveness of Egg Quality Assurance Programs, Mandatory Refrigeration, and Traceback Investigations to Mitigate Egg-Associated Salmonella enteritidis Infections in the United States
Kimberlee
Musser, New York, State Department of Health, Albany,
NY
Rapid Molecular Identification
of B. anthracis in New York State in Response to
Recent Bioterrorism Incidents
|
N- |
Allison Naleway, Marshfield Medical
Research Foundation, Marshfield, WI
Lyme Disease Incidence
in Wisconsin: A Comparison of State Reported Rates with Rates
from a Population-Based Cohort
|
O- |
Sarah
O'Brien, Public Health Laboratory Service, London, United
Kingdom
Campylobacter coliWhat’s
the Big Deal?
Daniel O'Leary, CDC, Fort Collins,
CO
Clinical Management and Outcomes of Lyme Disease in Wisconsin
Albert Osterhaus, University of Rotterdam,
Rotterdam, The Netherlands
The New Human Metapneumovirus
Michael Osterholm, University of
Minnesota Academic Health Center, Minneapolis, MN
The Globalization of Our Food Supply: Implications for Emerging Infections
Eric
Ottesen, Lymphatic Filariasis Support Center, Rollins
School of Public Health, Emory University, Atlanta, GA
Eradication of Lymphatic
Filariasis and Onchocerciasis
|
P- |
Carol
Palmer, University of Florida, Gainesville, FL
Increasing Detection of Malaria
in U.S. Hospitals Using the OptiMAL Rapid Diagnostic Test
O.K.
Pannenborg, The World Bank, Washington, DC
Emerging Infectious Diseases:
The World Bank Perspective
Philippe Parola, Harvard School of
Public Health, Boston, MA
Emerging Rickettsioses of the Thai-Myanmar Border
Michele Pearson, CDC, Atlanta, GA
Anthrax in the U.S. Postal System
Carmen Pérez-Guerra, CDC, San Juan,
PR
Bringing Dengue Prevention
Down to Earth: Evaluation of a Head Start Project in Puerto
Rico
Trish Perl, Johns Hopkins Hospital,
Baltimore, MD
The Role of Healthcare Systems in
Bioterrorism Preparedness
C.J. Peters, University of Texas,
Medical Branch, Galveston, TX
Emerging Vectorborne Disease:
The Case of Yellow Fever
Denise
Pettit, Division of Consolidated Laboratory Services,
Richmond, VA
Laboratory Response in the Commonwealth
of Virginia to the Intentional Release of Bacillus anthracis
Q. Phan, Connecticut Department of
Public Health, Hartford, CT
Epidemiology of Shiga
Toxin-Producing Escherichia coli (STEC) Infections in Connecticut, February 1, 2000-January 31, 2001
Silvio
Pitlik, Rabin Medical Center, Petah Tikvah, Israel
Failure to Detect C. pneumoniae
in Atherosclerotic Specimens
Alexander
Platonov, Central Research Institute of Epidemiology,
Moscow, Russian Federation
Microheterogenicity of the Volgograd
Clone of West Nile Virus
Richard
Platt, Ambulatory Care and Prevention, Harvard Medical
School, Boston, MA
Syndromic Surveillance in a Managed
Care Setting
Poly
Potter, CDC, Atlanta, GA
Behind the Scenes at the Emerging Infectious
Disease Journal
|
R- |
J. Reefhuis, CDC, Atlanta, GA
Letters from Trenton: The Anthrax
Investigation at the Source, New Jersey, 2001
Russell
Regnery,
CDC, Atlanta, GA
Virology and Diagnosis of
Smallpox
Ann
Reid, Armed Forces Institute of Pathology, Washington, DC
Virology of 1918 Flu Pandemic
David Relman, Stanford University,
Stanford, CA
Multiple Array Technology
to Look for mRNA Patterns Associated with Disease and Pathogens
Yuri Roldán-Aragón, National
Institute of Medical Science and Nutrition, Mexico City, Mexico
Recurrent Histoplasmosis Outbreaks
in Acapulco, Mexico
Blair
Rosen, New York State Department of Health, Slingerlands,
NY
Detection and Typing of Enterovirus
in Cerebrospinal Fluid
Shannon Rossiter, CDC, Atlanta, GA
Emerging Fluoroquinolone Resistance
among Non-Typhoidal Salmonella in the United States:
NARMS 1996-2000
Ernesto
Ruiz-Tiben, CDC, Atlanta, GA
Eradication of Dracunculiasis
Charles
Rupprecht, CDC, Atlanta, GA
Preventing Human Disease by Controlling
Pathogen Transmission in the Animal Reservoir
|
S- |
Diaa Salman, U.S. Naval Medical Research
Unit No 3., Cairo, Egypt
Acute Respiratory Virus Surveillance
in Cairo and Alexandria, Egypt, July 2000-June 2001
Abigail
Salyers, American Society for Microbiology, Washington,
DC
Implications of Gene
Transfer and Inducible Resistance for Successful Therapy
Matthew
Samore, University of Utah, Salt Lake City, UT
Computerized Decision
Support for Appropriate Antimicrobial Drug Prescribing
Alicia
Sánchez-Fauquier, Centro Nacional de Microbiología, Madrid,
Spain
Incidence and Type Distribution
of Astrovirus Among Spanish Children
Merle
Sande, University of Utah, Salt Lake City, UT
First Encounters with New Diseases: The
Clinician's Perspective
Peter
Schantz, CDC, Atlanta, GA
Eradication of T. solium
Cysticercosis
Joni Scheftel, Minnesota Department
of Health, Minneapolis, MN
Yersinia enterocolitica
Surveillance in
Minnesota
Gabriel
Schmunis, Pan American Health Organization, Washington,
DC
CDC-PAHO Collaboration:
Surveillance of Emerging/Reemerging Diseases in the Amazon
and the Southern Cone Region
Eradication of Chagas Disease
Pritha Sen, CDC, Atlanta, GA
A Greenhouse Study to Model Potential
Field Use of Genetically Modified Bacterial Symbionts for
Chagas' Disease Control
Scott
Seys, Wyoming Department of Health, Cheyenne, WY
Coordinating Environmental
Public Health Practice with Epidemiology and Laboratory Analysis:
A Waterborne Outbreak of "Norwalk-like Virus" in the Big Horn
Mountains of Wyoming
Kennedy
Shortridge, University of Hong Kong, Queen Mary Hospital,
Hong Kong
Shared Animal and Human Influenza Viruses:
A Role in the Next Pandemic?
Sanjay Shukla, Marshfield Medical
Research Foundation, Marshfield, WI
Determination of Allelic Diversity in the mec Operon of Methicillin-Resistant Staphylococcus
aureus in Wisconsin
Gustavo
Sierra, Finlay Institute, Havana, Cuba
Group B Meningococcal Vaccines
Sayomporn
Sirinavin, Mahidol University, Bangkok, Thailand
Promoting Appropriate
Antimicrobial Drug Use in Developing Countries
Brett Slater, New York State Department
of Health, Slingerlands, NY
Detection of La Crosse Virus in
Cerebrospinal Fluid and Tissues by Reverse Transcription-Polymerase
Chain Reaction
Theo
Sloots, Royal Children's Hospital and Royal Brisbane Hospital,
Brisbane, Australia
First Isolation of Human Metapneumovirus
in Australia
Perry Smith, New York State Department
of Health, Albany, NY
Lessons Learned from
Implementing Electronic Laboratory Reporting, New York State
Andre
Sofair, Connecticut Emerging Infections Program, New Haven,
CT
Prevalence of Hepatitis C and
other Chronic Liver Disease Etiologies in Primary Care Practices
Padmini
Srikantiah, CDC, Atlanta, GA
An Outbreak of Salmonella
Javiana Associated with Amphibian ContactMississippi,
2001
Mike
Starr, University of British Columbia Centre for Disease
Control, Vancouver, BC, Canada
Outbreak of Cryptococcus
neoformans var. gattii in a Restricted Zone in British Columbia
Bill
Steiger, U.S. Department of Health and Human Services,
Washington DC
Global Fund to Fight HIV/AIDS, TB, and Malaria (New Political/Economic Model for Addressing
Priority Infectious Diseases)
Matthew Stone, University of Texas-Houston,
Houston, TX
Modeling Tuberculosis Dissemination
in Harris County, Texas, 1995-1998, with Spatial Analysis
and Geographic Information Systems (GIS)
Patty
Stonesifer, Executive Director, Bill and Melinda Gates
Foundation, Seattle, WA
Keynote Session
Michael Stoto, The Rand Corporation,
Arlington, VA
Using CUSUM Techniques to Identify Influenza Outbreaks
Nancy Strockbine, CDC, Atlanta, GA
Real-time Fluorescence PCR Assays
for the Detection and Characterization of Heat-Labile and Heat-Stable Enterotoxin Genes from Enterotoxigenic Escherichia
coli
Balasubra
Swaminathan, CDC, Atlanta, GA
PulseNet and Beyond
Ellen
Swanson, Minnesota Department of Health, Minneapolis,
MN
Three Outbreaks of E. coli O157 Infections Due to Retail Ground Beef in Minnesota, 2000: Detection, Investigation, and Characteristics
|
T- |
Bruce Tempest, Gallup, NM
Hantavirus Pulmonary Syndrome
E.J. Threlfall, Central Public Health
Laboratory, London, United Kingdom
Molecular Characterization of a Multiresistant Strain of Salmonella enterica serotype
Typhimurium DT204b Responsible for an International Outbreak of Salmonellosis
Paavo
Toivanen, Turku University, Turku, Finland
Intestinal Anaerobic Bacteria
in Early Rheumatoid Arthritis
|
U- |
Fons UytdeHaag, Crucell Holland BV,
Leiden, The Netherlands
PER.C6: A Human Designer Cell Line Providing a Pandemic-Proof Platform for the Manufacturing of Safe Influenza
Vaccines |
V- |
Yvonne
van Duynhoven, National Institute of Public Health and
the Environment, Bilthoven, The Netherlands
Enhanced Laboratory-Based
Surveillance of Shiga Toxin-Producing Escherichia coli
O157, the Netherlands
Transmission
of the Main Viral Pathogens Causing Gastroenteritis, NLV, SLV, and Rotavirus
J.K. Varma, CDC, Atlanta, GA
Antimicrobial Resistance in Salmonella
is Associated with Increased Hospitalization: NARMS 1996-2000
Cecile Viboud, INSERM U444, Paris
cedex 12, France
Geographical Coherence of Influenza Epidemics in the U.S., France, and Australia: 1978-1998
|
W- |
Peter
J. Walker, CSIRO Livestock Industries, Indooroopilly,
Australia
Impact of Infectious Agents on Farming
and Food Production
Susan
Wang, CDC, Atlanta, GA
Multi-Drug Resistant Neisseria
gonorrhoeae with Decreased Susceptibility to Cefixime,
Hawaii, 2001
Henrik Wegener, Danish Zoonosis Institute,
Denmark
Integrated Surveillance and Control
of Emerging Foodborne Diseases—The Successful Danish Experience
WHO Global Salm-Surv South America Working
Group, Instituto INEI-ANLIS "Carlos G. Malbran", Buenos
Aires, Argentina
A WHO Global Salm-Surv Retrospective
Study Examining Salmonella Serotypes in South America,
2000: Dominance of Salmonella Serotype Enteritidis
Marc-Alain
Widdowson, CDC, Atlanta, GA
Outbreak of Viral Gastroenteritis
and an Ill Baker Who Should Have Known Better: Novel Application of E-mail for Rapid Investigation
Steve Wiersma, Florida Department
of Health, Tallahassee, FL
Inhalation Anthrax in Florida
Robert
Will, Western General Hospital, Edinburgh, United Kingdom
The Unfolding Variant (vCJD) Epidemic
Jennifer
Wright, CDC,
Atlanta, GA
Outbreaks of Multidrug-Resistant
Salmonella Serotype Typhimurium Infections Associated
with Small Animal Veterinary Facilities in Idaho, Minnesota, and Washington, 1999
|
Y- |
Thomas
Yoshikawa, Charles R. Drew University of Medicine and
Science, Los Angeles, CA
Impact of Aging on the Epidemiology
of Infections in Adults
|
Z- |
Emily Zielinski-Gutiérrez, CDC, Fort
Collins, CO
The Essential Role of Behavioral
and Social Sciences in the Prevention of Emerging Infectious
Diseases
|
|
|